Projects funded by the NCN

Impact of pharmacogenetic profiles on depression treatment outcomes

Call: SONATINA 5 , Panel: NZ2

Principal investigator: dr Małgorzata Maria Borczyk

Instytut Farmakologii PAN

Pharmacogenetics of thiopurine drugs in patients with inflammatory bowel disease - application of the newest methods of ...

Call: SONATA 12 , Panel: NZ2

Principal investigator: dr Marzena Skrzypczak-Zielińska

Instytut Genetyki Człowieka PAN

Analysis of genetic factors associated with response to glucocorticoid in patient with inflammatory bowel disease

Call: PRELUDIUM 9 , Panel: NZ5

Principal investigator: Marcin Gabryel

Instytut Genetyki Człowieka PAN

Evaluation of an influence of interaction between clopidogrel and statins possessing different pharmacokinetic propertie...

Call: OPUS 8 , Panel: NZ7

Principal investigator: dr Marta Katarzyna Karaźniewicz-Łada

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Evaluation of influence of genetic factors associated with transport and metabolizm of immunosuppressive agents on blood...

Call: OPUS 5 , Panel: NZ2

Principal investigator: prof. Leszek Pączek

Warszawski Uniwersytet Medyczny, I Wydział Lekarski

The importance of pharmacogenetic factors in the individualization of therapy using immunosuppressive drugs in kidney tr...

Call: OPUS 2 , Panel: NZ7

Principal investigator: dr Anna Bogacz

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Farmaceutyczny

Pharmacogenetics in predicting metabolic ratio of tamoxifen; genome-wide association study linked to mass spectrometry-b...

Call: OPUS 1 , Panel: NZ2

Principal investigator: dr hab. Ewa Elżbieta Hennig

Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie